Oculogica is a groundbreaking company based in New Richmond, WI that has developed EyeBOX, the first FDA-cleared concussion assessment that does not require a baseline test. This innovative technology measures abnormalities in eye movements to aid in the diagnosis of concussions, providing immediate screening results in less than 4 minutes. With its objective and clinically-validated approach, EyeBOX offers a baseline-free, non-invasive solution that increases diagnostic consistency and enhances communication between healthcare providers, patients, and their families.
By combining neuroscience and proprietary algorithms, EyeBOX revolutionizes concussion diagnosis by providing an objective assessment of a patient's neurological health. This visionary breakthrough takes the guesswork out of diagnosis, offering an easy-to-use and non-invasive process that delivers an objective score and eye-tracking metrics immediately after the test. With its wide patient range and reimbursable test, EyeBOX is at the forefront of concussion diagnosis, elevating healthcare services and ensuring accurate assessments for patients of all ages.
Generated from the website